Improving 3D Chemical Visualization of Subsurface Structures

| February 19, 2020

article image
A Raman microscope combines a Raman spectrograph and a light microscope to gain chemical and structural information from materials down to the micron scale. Raman spectroscopy observes when the wavelength of light changes as it interacts with a molecule. The different wavelengths seen in Raman scattering can identify and study vibrational, rotational, and bending forces within chemical bonds of a molecule.

Spotlight

F-star Biotechnology Ltd

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to rapidly create bispecific antibodies with properties virtually identical to a typical antibody. This offers unprecedented ease in the discovery, development, and manufacturing of bispecific antibody products. F-star has currently one programme in the clinic with a second immuno-oncology programme heading toward IND. The Company has built a comprehensive IP estate around its technology and product pipeline, with over 50 patent applications filed and over 25 granted patents.

OTHER ARTICLES

Setting record straight on testing harm in chemicals

Article | February 13, 2020

The modern world is built on chemicals, be it the medicines we use, or cleaning fluids, crop protection products, or the raw materials for everything from laptops and mobile phones to clothes and furniture. Across all, we have created an entire modern society with chemicals, and, as a result, constantly stretched the size of the world population we can feed, clothe and shelter. Yet, balancing all the gains from the modern chemistry around us against any negative environmental and human impact has been a rising concern, making for ever greater focus on testing and on risk assessment.

Read More

Petrochemicals in PA: What You Need to Know

Article | February 13, 2020

A bill recently passed by the Pennsylvania General Assembly would subsidize the use of fracked gas to produce petrochemicals. At some point—i.e., at a time chosen by the state Senate—H B 1100 will be sent to Governor Wolf, who has promised a veto despite override threats. Meanwhile, Pennsylvanians are trying to understand the bill and its potential impacts. That hasn't been easy, because as with the petrochemical subsidy bills Pennsylvania enacted in 2012, the General Assembly has not held a single hearing on the legislation. The purpose of this blog is to help fill that gap.

Read More

Exploring the potential impact of Brexit on the chemical industry

Article | February 13, 2020

With Brexit officially underway, the UK has entered the transition period during which arrangements affecting the chemical industry will be made. The chemical sector produces around £50 billion worth of exports annually, and 60% of this goes directly to the European Union [1]. 75% of our chemical imports also come from the EU [1], making Brexit a critical time for the sector. The future of trading is yet to be established. Now is a pivotal period during which the chemical industry, stakeholders and the government need to work together to determine this future, in order to allow for a continuation of chemistry enabled growth.

Read More

CHEMICAL SPILL PREVENTION

Article | February 13, 2020

When it comes to your workplace, nothing should be prioritized over the safety of your employees. As your greatest asset to your business, they should feel safe in their work environment. Maintaining a safe work environment is a particularly important consideration for companies who work with or store hazardous materials. And it is not only critical for the appeasement of the Occupational Health and Safety Administration (OSHA) and the Environmental Protection Agency (EPA) requirements but the well-being and safety of your employees. That’s why, in this article, we will discuss chemical spill prevention in your workplace facility.

Read More

Spotlight

F-star Biotechnology Ltd

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to rapidly create bispecific antibodies with properties virtually identical to a typical antibody. This offers unprecedented ease in the discovery, development, and manufacturing of bispecific antibody products. F-star has currently one programme in the clinic with a second immuno-oncology programme heading toward IND. The Company has built a comprehensive IP estate around its technology and product pipeline, with over 50 patent applications filed and over 25 granted patents.

Events